These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27242953)

  • 1. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
    Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
    Front Oncol; 2016; 6():109. PubMed ID: 27242953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
    Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
    Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered tumor-cell glycosylation promotes metastasis.
    Häuselmann I; Borsig L
    Front Oncol; 2014; 4():28. PubMed ID: 24592356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial Lectins in Health and Neurological Diseases.
    Siew JJ; Chern Y
    Front Mol Neurosci; 2018; 11():158. PubMed ID: 29867350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan Chains of Gangliosides: Functional Ligands for Tissue Lectins (Siglecs/Galectins).
    Ledeen RW; Kopitz J; Abad-Rodríguez J; Gabius HJ
    Prog Mol Biol Transl Sci; 2018; 156():289-324. PubMed ID: 29747818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional roles of protein glycosylation in human maternal-fetal crosstalk.
    Zhong J; Li J; Burton GJ; Koistinen H; Cheung KW; Ng EHY; Yao Y; Yeung WSB; Lee CL; Chiu PCN
    Hum Reprod Update; 2024 Jan; 30(1):81-108. PubMed ID: 37699855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycan-Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them.
    Kremsreiter SM; Kroell AH; Weinberger K; Boehm H
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy.
    Gupta B; Sadaria D; Warrier VU; Kirtonia A; Kant R; Awasthi A; Baligar P; Pal JK; Yuba E; Sethi G; Garg M; Gupta RK
    Semin Cancer Biol; 2022 May; 80():87-106. PubMed ID: 32068087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis.
    Shu L; Lin S; Zhou S; Yuan T
    Platelets; 2024 Dec; 35(1):2315037. PubMed ID: 38372252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances toward the development of inhibitors to attenuate tumor metastasis via the interruption of lectin-ligand interactions.
    Rachel H; Chang-Chun L
    Adv Carbohydr Chem Biochem; 2013; 69():125-207. PubMed ID: 24274369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins.
    O'Sullivan JA; Carroll DJ; Bochner BS
    Front Med (Lausanne); 2017; 4():116. PubMed ID: 28824909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection.
    Pinho SS; Alves I; Gaifem J; Rabinovich GA
    Cell Mol Immunol; 2023 Oct; 20(10):1101-1113. PubMed ID: 37582971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.
    Pace A; Scirocchi F; Napoletano C; Zizzari IG; D'Angelo L; Santoro A; Nuti M; Rahimi H; Rughetti A
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycobiology simplified: diverse roles of glycan recognition in inflammation.
    Schnaar RL
    J Leukoc Biol; 2016 Jun; 99(6):825-38. PubMed ID: 27004978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs).
    Sato S; St-Pierre C; Bhaumik P; Nieminen J
    Immunol Rev; 2009 Jul; 230(1):172-87. PubMed ID: 19594636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Galectins With Glycomimetics.
    Bertuzzi S; Quintana JI; Ardá A; Gimeno A; Jiménez-Barbero J
    Front Chem; 2020; 8():593. PubMed ID: 32850631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.
    Boligan KF; Mesa C; Fernandez LE; von Gunten S
    Cell Mol Life Sci; 2015 Apr; 72(7):1231-48. PubMed ID: 25487607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
    Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
    Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
    Compagno D; Gentilini LD; Jaworski FM; Pérez IG; Contrufo G; Laderach DJ
    Glycobiology; 2014 Oct; 24(10):899-906. PubMed ID: 24939371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.